Mimedx (MDXG) Revenue Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 54.05% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -6.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.29% |
| Dec 31, 2025 | 16.66% |
| Sep 30, 2025 | 18.88% |
| Jun 30, 2025 | 13.81% |
| Mar 31, 2025 | 14.41% |
| Dec 31, 2024 | 22.28% |
| Sep 30, 2024 | 10.05% |
| Jun 30, 2024 | 8.56% |
| Mar 31, 2024 | 12.20% |
| Dec 31, 2023 | 8.20% |
| Sep 30, 2023 | 8.31% |
| Jun 30, 2023 | 14.84% |
| Mar 31, 2023 | 5.10% |
| Dec 31, 2022 | -0.89% |
| Sep 30, 2022 | -8.67% |
| Jun 30, 2022 | -0.27% |
| Mar 31, 2022 | -3.99% |
| Dec 31, 2021 | -18.13% |
| Sep 30, 2021 | -10.15% |
| Jun 30, 2021 | -10.61% |
| Mar 31, 2021 | -10.68% |
| Dec 31, 2020 | -7.94% |
| Sep 30, 2020 | -8.52% |
| Jun 30, 2020 | -12.65% |
| Mar 31, 2020 | -3.54% |
| Dec 31, 2019 | 3.02% |
| Sep 30, 2019 | 11.31% |
| Jun 30, 2019 | 5.55% |
| Mar 31, 2019 | 7.64% |
| Dec 31, 2018 | 21.33% |
| Sep 30, 2018 | 21.06% |
| Jun 30, 2018 | 27.83% |
| Mar 31, 2018 | 27.32% |
| Dec 31, 2017 | 30.45% |
| Sep 30, 2017 | 35.83% |
| Jun 30, 2017 | 46.55% |
| Mar 31, 2017 | 52.08% |
| Dec 31, 2016 | 57.18% |
| Sep 30, 2016 | 58.71% |
| Jun 30, 2016 | 61.89% |
| Mar 31, 2016 | 66.53% |
| Dec 31, 2015 | 70.22% |
| Sep 30, 2015 | 83.34% |
| Jun 30, 2015 | 110.69% |
| Mar 31, 2015 | 122.40% |
| Dec 31, 2014 | 146.71% |
| Sep 30, 2014 | 149.73% |
| Jun 30, 2014 | 136.66% |
| Mar 31, 2014 | 165.64% |